Research Paper Volume 13, Issue 5 pp 7549—7569

Preclinical systematic review of ginsenoside Rg1 for cognitive impairment in Alzheimer’s disease

class="figure-viewer-img"

Figure 8. Forest plot of the expression of BDNF for the ginsenosdie-Rg1 group versus a control group.